screening

Pradipta Ghosh has plans to revolutionize the drug discovery pipeline.

Screens of hundreds of drug excipients reveal that some can interact with biological targets, contradicting their FDA categorization as inert.

Onsite testing at wastewater treatment plants could aid efforts to monitor for outbreaks of COVID-19 around the world, but such technologies are in the early stages of development.

Lesions in the lungs of patients with pneumonia caused by a SARS-CoV-2 infection are distinct from those caused by bacteria.

An inflatable biosafety laboratory may help meet the global need for testing infrastructure during the COVID-19 pandemic.

Researchers could accurately detect life-threatening vascular complications in type 2 diabetes patients by analyzing hydroxymethylated cytosines in freely circulating DNA.

US Preventive Services Task Force recommends genetic testing for mutations in the cancer-related genes for more—but not all—women.

Robert Guthrie’s blood test for the metabolic disorder phenylketonuria launched a worldwide movement to screen every baby for the disease soon after birth.

Fly avatars bearing multiple genetic changes akin to those of a cancer patient lead to a tailor-made treatment that has shrunk the patient’s tumors.

Two studies, taken together, imply that sequencing can identify a genetic cause for ultrasound abnormalities in roughly 10 percent of cases.

3-D balls of cells can be used to screen for potential cancer drugs.

A new study reveals similarities between the transmissible cancers that infect the endangered marsupials, and hints at ways to treat them.

Mutations in the TP53 gene appear to influence the prognosis and likelihood of future cancers in pediatric leukemia patients.